← Eichor
Study identifier: NCT06737016 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Efficacy and Safety of Tamsulosin for Children with Posterior Urethral Valve.

Condition: Posterior Urethral Valve  ·  Sponsor: Mansoura University

PhasePhase 3
Planned participants50
Who can joinMale, N/A to 12 Years
Healthy volunteersNo

About this study

To determine whether there is a role for Tamsulosin, A Selective Alpha-1 Adrenergic Blocker, as therapy in children with Posterior Urethral Valve post valve ablation , and whether there are side effects involved.

This description comes directly from the study's public registry record.

Talk to the study team

Mohamed Hussiny  ·  +201064156383  ·  mohamedhussiny1@yahoo.com

Always discuss trial participation with your own doctor first.

Locations (1)

Mansoura Urology and Nephrology CenterAl Mansurah, Dakahlia Governorate, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06737016